ATE384739T1 - Für den menschlichen vanilloid-rezeptor vr3 kodierende dns - Google Patents

Für den menschlichen vanilloid-rezeptor vr3 kodierende dns

Info

Publication number
ATE384739T1
ATE384739T1 AT01908798T AT01908798T ATE384739T1 AT E384739 T1 ATE384739 T1 AT E384739T1 AT 01908798 T AT01908798 T AT 01908798T AT 01908798 T AT01908798 T AT 01908798T AT E384739 T1 ATE384739 T1 AT E384739T1
Authority
AT
Austria
Prior art keywords
dna coding
receptor
host cells
vanilloid receptor
recombinant
Prior art date
Application number
AT01908798T
Other languages
English (en)
Inventor
Adrienne Dubin
Arne Huvar
Charles Glass
Mark Erlander
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE384739T1 publication Critical patent/ATE384739T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
AT01908798T 2000-02-08 2001-02-01 Für den menschlichen vanilloid-rezeptor vr3 kodierende dns ATE384739T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/500,123 US6455278B1 (en) 2000-02-08 2000-02-08 DNA encoding human vanilloid receptor VR3

Publications (1)

Publication Number Publication Date
ATE384739T1 true ATE384739T1 (de) 2008-02-15

Family

ID=23988135

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01908798T ATE384739T1 (de) 2000-02-08 2001-02-01 Für den menschlichen vanilloid-rezeptor vr3 kodierende dns

Country Status (11)

Country Link
US (3) US6455278B1 (de)
EP (1) EP1272514B1 (de)
JP (1) JP2004500085A (de)
AT (1) ATE384739T1 (de)
AU (1) AU781228B2 (de)
CA (1) CA2400299A1 (de)
DE (1) DE60132571T2 (de)
ES (1) ES2300318T3 (de)
MX (1) MXPA02007751A (de)
NZ (1) NZ520485A (de)
WO (1) WO2001058945A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455278B1 (en) * 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
HUP0300489A3 (en) * 2000-02-25 2006-06-28 Daiichi Seiyaku Co Novel protein and gene encoding the same
JP3501775B2 (ja) * 2000-05-31 2004-03-02 ファイザー株式会社 ヒトバニロイド受容体様タンパク質
GB0026114D0 (en) * 2000-10-25 2000-12-13 Smithkline Beecham Plc New use
CN102199197B (zh) * 2011-04-13 2013-03-27 安徽医科大学 一种具有自组装钾通道功能的多肽及其应用
CN106537149A (zh) 2014-04-01 2017-03-22 宝洁公司 用于筛选色氨酸通道的方法
US10538881B2 (en) 2016-10-25 2020-01-21 The Procter & Gamble Company Fibrous structures
CA3036897C (en) 2016-10-25 2021-11-16 The Procter & Gamble Company Fibrous structures

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
WO1999009140A1 (en) * 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
WO1999037765A1 (en) 1998-01-27 1999-07-29 Smithkline Beecham Plc Human vanilloid receptor homologues
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
EP1144628A3 (de) * 1999-11-12 2002-02-27 Abbott Laboratories Menschliches vanilloid-rezeptorgen
US6455278B1 (en) 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
JP3501775B2 (ja) * 2000-05-31 2004-03-02 ファイザー株式会社 ヒトバニロイド受容体様タンパク質

Also Published As

Publication number Publication date
AU3663001A (en) 2001-08-20
ES2300318T3 (es) 2008-06-16
DE60132571D1 (de) 2008-03-13
AU781228B2 (en) 2005-05-12
WO2001058945A1 (en) 2001-08-16
JP2004500085A (ja) 2004-01-08
EP1272514B1 (de) 2008-01-23
CA2400299A1 (en) 2001-08-16
DE60132571T2 (de) 2009-02-05
US7186803B2 (en) 2007-03-06
EP1272514A1 (de) 2003-01-08
EP1272514A4 (de) 2004-12-15
US7094877B2 (en) 2006-08-22
US20030032097A1 (en) 2003-02-13
MXPA02007751A (es) 2004-09-10
NZ520485A (en) 2004-05-28
US6455278B1 (en) 2002-09-24
US20050084897A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
ATE310098T1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
LU92780I2 (fr) Trastuzumab et hyaluronidase humaine recombinante
DE69428719D1 (de) Für das yap3 signalpeptid kodierendes dna-konstrukt
DE60140218D1 (de) Expressionsvektor für tierische zellen
BR9810701A (pt) Proteìna "swollenina" de trichoderma reesei e seqâências de codificação de dna
DE69823501D1 (de) Verwendung von wolinella succinogenes asparaginase zur behandlung von asparagin-abhängiger krankheiten
ATE459644T1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
ATE384739T1 (de) Für den menschlichen vanilloid-rezeptor vr3 kodierende dns
WO2000063415A8 (en) Dna encoding the human vanilloid receptor vr1
AR053931A2 (es) Secuencia de adn que codifica una proteina de a. thaliana que posee actividad de delta -5,7-esterol, delta-7-reductasa, proteina delta-7red
ATE283368T1 (de) Für die glutamatabhängigen chloridkanäle kodierende dna
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
FI971896A0 (fi) BMP-tyyppi II-reseptoria koodaava cDNA
DK1287134T3 (da) Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf
ATE372375T1 (de) Für den bradykinin-b1-rezeptor kodierende dna
ATE353359T1 (de) Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dna
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
FR2770853B1 (fr) Gene codant pour la thanatine, vecteur le contenant et plantes transformees obtenues resistantes aux maladies
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
MXPA02011938A (es) Adn que codifica para un receptor de histamina de mamifero del subtipo h4.
ATE309359T1 (de) Epil/plazentin
ES2012283A6 (es) Procedimiento de obtencion de una proteina de endotoxina de efecto insecticida.
FR2665177B1 (fr) Gene recombinant codant pour une proteine a activite endochitinase et/ou lysozyme.
WO2003040343A3 (en) Polynucleotide and polypeptide sequences of canine cathepsin s
WO2000071741A3 (en) Dna encoding a human subunit of the 5-ht3 serotonin receptor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties